BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koch K, Wrona A, Dikomey E, Borgmann K. Impact of homologous recombination on individual cellular radiosensitivity. Radiotherapy and Oncology 2009;90:265-72. [DOI: 10.1016/j.radonc.2008.07.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Nagathihalli NS, Nagaraju G. RAD51 as a potential biomarker and therapeutic target for pancreatic cancer. Biochim Biophys Acta 2011;1816:209-18. [PMID: 21807066 DOI: 10.1016/j.bbcan.2011.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
2 D’andrea FP, Safwat A, Kassem M, Gautier L, Overgaard J, Horsman MR. Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiotherapy and Oncology 2011;99:373-8. [DOI: 10.1016/j.radonc.2011.05.086] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
3 Beucher A, Deckbar D, Schumann E, Krempler A, Frankenberg-Schwager M, Löbrich M. Elevated radiation-induced γH2AX foci in G2 phase heterozygous BRCA2 fibroblasts. Radiother Oncol 2011;101:46-50. [PMID: 21665305 DOI: 10.1016/j.radonc.2011.05.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Fontana AO, Augsburger MA, Grosse N, Guckenberger M, Lomax AJ, Sartori AA, Pruschy MN. Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. Radiotherapy and Oncology 2015;116:374-80. [DOI: 10.1016/j.radonc.2015.08.014] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
5 Magwood AC, Malysewich MJ, Cealic I, Mundia MM, Knapp J, Baker MD. Endogenous levels of Rad51 and Brca2 are required for homologous recombination and regulated by homeostatic re-balancing. DNA Repair (Amst) 2013;12:1122-33. [PMID: 24210700 DOI: 10.1016/j.dnarep.2013.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
6 Rodemann HP, Wouters BG. Frontiers in molecular radiation biology/oncology. Radiotherapy and Oncology 2011;101:1-6. [DOI: 10.1016/j.radonc.2011.09.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Wennemers M, Bussink J, Grebenchtchikov N, Sweep FC, Span PN. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity. Radiotherapy and Oncology 2011;101:198-202. [DOI: 10.1016/j.radonc.2011.05.057] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
8 Heim D, Gil-Ibanez I, Herden J, Parplys AC, Borgmann K, Schmidt-Arras D, Lohse AW, Rose-John S, Wege H. Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response. Oncotarget 2016;7:55639-48. [PMID: 27489351 DOI: 10.18632/oncotarget.10956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Parplys AC, Seelbach JI, Becker S, Behr M, Wrona A, Jend C, Mansour WY, Joosse SA, Stuerzbecher HW, Pospiech H, Petersen C, Dikomey E, Borgmann K. High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation. Cell Cycle 2015;14:3190-202. [PMID: 26317153 DOI: 10.1080/15384101.2015.1055996] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
10 Jeggo PA, Geuting V, Löbrich M. The role of homologous recombination in radiation-induced double-strand break repair. Radiother Oncol 2011;101:7-12. [PMID: 21737170 DOI: 10.1016/j.radonc.2011.06.019] [Cited by in Crossref: 130] [Cited by in F6Publishing: 114] [Article Influence: 11.8] [Reference Citation Analysis]
11 Tkacz-Stachowska K, Lund-Andersen C, Velissarou A, Myklebust JH, Stokke T, Syljuåsen RG. The amount of DNA damage needed to activate the radiation-induced G2 checkpoint varies between single cells. Radiother Oncol 2011;101:24-7. [PMID: 21722983 DOI: 10.1016/j.radonc.2011.05.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
12 Rodemann HP. Molecular radiation biology: Perspectives for radiation oncology. Radiotherapy and Oncology 2009;92:293-8. [DOI: 10.1016/j.radonc.2009.08.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
13 Banáth JP, Klokov D, MacPhail SH, Banuelos CA, Olive PL. Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer 2010;10:4. [PMID: 20051134 DOI: 10.1186/1471-2407-10-4] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 9.8] [Reference Citation Analysis]
14 Peter Rodemann H, Wouters BG. Molecular and translational radiation biology/oncology: What’s up? Radiotherapy and Oncology 2011;99:257-61. [DOI: 10.1016/j.radonc.2011.06.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
15 Menegakis A, Eicheler W, Yaromina A, Thames HD, Krause M, Baumann M. Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours. Radiotherapy and Oncology 2011;100:137-44. [DOI: 10.1016/j.radonc.2011.07.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
16 Harding SM, Coackley C, Bristow RG. ATM-dependent phosphorylation of 53BP1 in response to genomic stress in oxic and hypoxic cells. Radiotherapy and Oncology 2011;99:307-12. [DOI: 10.1016/j.radonc.2011.05.039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
17 Kriegs M, Kasten-pisula U, Rieckmann T, Holst K, Saker J, Dahm-daphi J, Dikomey E. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining. DNA Repair 2010;9:889-97. [DOI: 10.1016/j.dnarep.2010.05.005] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 7.3] [Reference Citation Analysis]
18 Pantelias GE, Terzoudi GI. A standardized G2-assay for the prediction of individual radiosensitivity. Radiotherapy and Oncology 2011;101:28-34. [DOI: 10.1016/j.radonc.2011.09.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
19 Miyatani T, Kurita N, Utsunomiya T, Iwata T, Nishioka M, Yoshikawa K, Higashijima J, Kashihara H, Takasu C, Fukushima M, Shimada M. Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer. Cancer Lett 2012;318:199-205. [PMID: 22178656 DOI: 10.1016/j.canlet.2011.12.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
20 Wilson PF, Nagasawa H, Fitzek MM, Little JB, Bedford JS. G2-phase chromosomal radiosensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls. Radiat Res 2010;173:62-70. [PMID: 20041760 DOI: 10.1667/RR1943.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
21 Brassat U, Balabanov S, Bali D, Dierlamm J, Braig M, Hartmann U, Sirma H, Günes C, Wege H, Fehse B. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells. Exp Hematol. 2011;39:66-76.e1-e2. [PMID: 20940029 DOI: 10.1016/j.exphem.2010.10.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
22 Martin NT, Nahas SA, Tunuguntla R, Fike F, Gatti RA. Assessing 'radiosensitivity' with kinetic profiles of γ-H2AX, 53BP1 and BRCA1 foci. Radiother Oncol 2011;101:35-8. [PMID: 21722985 DOI: 10.1016/j.radonc.2011.05.065] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
23 Tennstedt P, Fresow R, Simon R, Marx A, Terracciano L, Petersen C, Sauter G, Dikomey E, Borgmann K. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. Int J Cancer. 2013;132:2118-2126. [PMID: 23065657 DOI: 10.1002/ijc.27907] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 6.7] [Reference Citation Analysis]
24 Gutiérrez-Enríquez S, Ramón Y Cajal T, Alonso C, Corral A, Carrasco P, Cornet M, Sanz J, Ribas M, Baiget M, Diez O. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers. Breast Cancer Res Treat 2011;127:611-22. [PMID: 20625817 DOI: 10.1007/s10549-010-1017-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]